Symbols / ELV Stock $344.76 -0.44% Elevance Health, Inc.

Healthcare • Healthcare Plans • United States • NYQ
ELV (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Healthcare Plans
CEO Ms. Gail Koziara Boudreaux
Exch · Country NYQ · United States
Market Cap 74.87B
Enterprise Value 69.78B
Income 5.24B
Sales 200.42B
FCF (ttm) 4.30B
Book/sh 198.81
Cash/sh 170.72
Employees 96,129
Insider 10d —
IPO Oct 30, 2001
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 29.03%
P/E 14.60
Forward P/E 11.81
PEG 1.32
P/S 0.37
P/B 1.73
P/C —
EV/EBITDA 8.17
EV/Sales 0.35
Quick Ratio 1.33
Current Ratio 1.48
Debt/Eq 72.30
LT Debt/Eq —
EPS (ttm) 23.62
EPS next Y 29.19
EPS Growth -16.80%
Revenue Growth 2.60%
EPS Gr Q/Q -19.20%
Rev Gr Q/Q —
Earnings (next) 2026-07-16
Earnings (prior) 2026-04-22
ROA 3.98%
ROE 12.09%
ROIC —
Gross Margin 25.89%
Oper. Margin 5.30%
Profit Margin 2.62%
Shs Outstand 217.16M
Shs Float 216.66M
Insider Own 0.19%
Instit Own 94.83%
Short Float 2.28%
Short Ratio 2.83
Short Interest 4.42M
52W High 427.54
vs 52W High -19.36%
52W Low 273.71
vs 52W Low 25.96%
Beta 0.50
Impl. Vol. 36.24%
Rel Volume 0.62
Avg Volume 2.03M
Volume 1.25M
Target (mean) $386.86
Tgt Median $391.00
Tgt Low $331.00
Tgt High $474.00
# Analysts 21
Recom Buy
Prev Close $346.29
Price $344.76
Change -0.44%
About

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$386.86
Mean price target
2. Current target
$344.76
Latest analyst target
3. DCF / Fair value
$356.30
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$344.76
Low
$331.00
High
$474.00
Mean
$386.86

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-24 main Barclays Overweight → Overweight $408
2026-04-24 main Guggenheim Buy → Buy $399
2026-04-23 main Evercore ISI Group In-Line → In-Line $360
2026-04-23 main Baird Neutral → Neutral $331
2026-04-20 main Jefferies Buy → Buy $391
2026-04-13 main Truist Securities Buy → Buy $375
2026-04-08 init Evercore ISI Group — → In-Line $345
2026-03-11 main Mizuho Outperform → Outperform $350
2026-02-02 main JP Morgan Overweight → Overweight $397
2026-02-02 main Truist Securities Buy → Buy $390
2026-01-30 main Barclays Overweight → Overweight $393
2026-01-30 main Wells Fargo Overweight → Overweight $391
2026-01-29 main Guggenheim Buy → Buy $396
2026-01-22 main Guggenheim Buy → Buy $414
2026-01-08 up Wolfe Research Peer Perform → Outperform $425
2026-01-07 main Wells Fargo Overweight → Overweight $424
2026-01-05 main Barclays Overweight → Overweight $404
2025-12-19 down Deutsche Bank Buy → Hold $320
2025-12-18 main Morgan Stanley Equal-Weight → Equal-Weight $352
2025-11-26 main TD Cowen Buy → Buy $400
News
RSS: Latest ELV news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-12 SCHULMAN AMY W. Director — 26 $287.50 $7,475
2026-03-06 KENDRICK CHARLES MORGAN JR Officer — 3,196 $284.92 $910,604
2026-03-05 COLLIS STEVEN H Director — 3,000 $289.84 $869,520
2026-03-02 HAYTAIAN PETER D Officer — 2,865 $0.00 $0
2026-03-02 PENCZEK RONALD W Officer — 2,393 $0.00 $0
2026-03-02 LAVU RATNAKAR Chief Technology Officer — 11,903 $0.00 $0
2026-03-02 NORWOOD FELICIA F. Officer — 8,816 $0.00 $0
2026-03-02 KAYE MARK Chief Financial Officer — 16,579 $0.00 $0
2026-03-02 KENDRICK CHARLES MORGAN JR Officer — 6,549 $0.00 $0
2026-03-02 CRAIG RYAN R Officer — 2,976 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
199,125.00
+12.62%
176,810.00
+3.19%
171,340.00
+9.42%
156,595.00
Operating Revenue
199,125.00
+12.62%
176,810.00
+3.19%
171,340.00
+9.42%
156,595.00
Selling General And Administration
—
—
—
17,686.00
Other Operating Expenses
42,162.00
+6.00%
39,775.00
+6.41%
37,380.00
+21.62%
30,735.00
Total Expenses
192,415.00
+13.92%
168,906.00
+3.23%
163,625.00
+9.82%
148,995.00
Reconciled Depreciation
1,546.00
+10.98%
1,393.00
-20.17%
1,745.00
+4.18%
1,675.00
EBIT
8,112.00
-10.75%
9,089.00
+3.93%
8,745.00
+3.48%
8,451.00
Total Unusual Items
0.00
-100.00%
201.00
0.00
0.00
Total Unusual Items Excluding Goodwill
0.00
-100.00%
201.00
0.00
0.00
Special Income Charges
0.00
-100.00%
201.00
0.00
0.00
Other Special Charges
—
-201.00
—
—
Net Income
5,662.00
-5.32%
5,980.00
-0.12%
5,987.00
+1.58%
5,894.00
Pretax Income
6,710.00
-15.11%
7,904.00
+2.45%
7,715.00
+1.51%
7,600.00
Net Non Operating Interest Income Expense
-1,402.00
-18.31%
-1,185.00
-15.05%
-1,030.00
-21.03%
-851.00
Interest Expense Non Operating
1,402.00
+18.31%
1,185.00
+15.05%
1,030.00
+21.03%
851.00
Net Interest Income
-1,402.00
-18.31%
-1,185.00
-15.05%
-1,030.00
-21.03%
-851.00
Interest Expense
1,402.00
+18.31%
1,185.00
+15.05%
1,030.00
+21.03%
851.00
Other Income Expense
24,470.00
+8.13%
22,630.00
+16.34%
19,452.00
+29.87%
14,978.00
Tax Provision
1,049.00
-45.73%
1,933.00
+12.12%
1,724.00
+0.70%
1,712.00
Tax Rate For Calcs
0.00
-36.33%
0.00
+9.87%
0.00
-0.89%
0.00
Tax Effect Of Unusual Items
0.00
-100.00%
49.24
0.00
0.00
Net Income Including Noncontrolling Interests
5,661.00
-5.19%
5,971.00
-0.33%
5,991.00
+1.75%
5,888.00
Net Income From Continuing Operation Net Minority Interest
5,662.00
-5.32%
5,980.00
-0.12%
5,987.00
+1.58%
5,894.00
Net Income From Continuing And Discontinued Operation
5,662.00
-5.32%
5,980.00
-0.12%
5,987.00
+1.58%
5,894.00
Net Income Continuous Operations
5,661.00
-5.19%
5,971.00
-0.33%
5,991.00
+1.75%
5,888.00
Minority Interests
1.00
-88.89%
9.00
+325.00%
-4.00
-166.67%
6.00
Normalized Income
5,662.00
-2.85%
5,828.24
-2.65%
5,987.00
+1.58%
5,894.00
Net Income Common Stockholders
5,662.00
-5.32%
5,980.00
-0.12%
5,987.00
+1.58%
5,894.00
Diluted EPS
25.21
-1.83%
25.68
+1.82%
25.22
+1.65%
24.81
Basic EPS
25.28
-3.83%
26.29
+2.34%
25.69
+1.45%
25.32
Basic Average Shares
224.00
-1.53%
227.48
-2.40%
233.07
-2.05%
237.96
Diluted Average Shares
224.60
-3.56%
232.90
-1.90%
237.40
-2.22%
242.80
Diluted NI Availto Com Stockholders
5,662.00
-5.32%
5,980.00
-0.12%
5,987.00
+1.58%
5,894.00
Amortization
628.00
+8.28%
580.00
-34.46%
885.00
+15.38%
767.00
Depreciation And Amortization In Income Statement
628.00
+8.28%
580.00
-34.46%
885.00
+15.38%
767.00
Loss Adjustment Expense
148,223.00
+16.19%
127,567.00
+2.60%
124,330.00
+6.59%
116,642.00
Net Policyholder Benefits And Claims
148,223.00
+16.19%
127,567.00
+2.60%
124,330.00
+6.59%
116,642.00
Policyholder Benefits Ceded
72.00
+28.57%
56.00
-11.11%
63.00
+21.15%
52.00
Policyholder Benefits Gross
148,295.00
+16.20%
127,623.00
+2.60%
124,393.00
+6.60%
116,694.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
121,494.00
+3.94%
116,889.00
+7.31%
108,928.00
+6.01%
102,755.00
Cash Cash Equivalents And Short Term Investments
35,375.00
+5.63%
33,489.00
-7.34%
36,140.00
+8.40%
33,339.00
Cash And Cash Equivalents
9,491.00
+14.51%
8,288.00
+27.00%
6,526.00
-11.66%
7,387.00
Other Short Term Investments
25,884.00
+2.71%
25,201.00
-14.90%
29,614.00
+14.11%
25,952.00
Receivables
21,542.00
+12.96%
19,071.00
+6.75%
17,865.00
+11.35%
16,044.00
Accounts Receivable
10,073.00
+25.74%
8,011.00
+1.38%
7,902.00
+11.56%
7,083.00
Other Receivables
11,469.00
+3.70%
11,060.00
+11.01%
9,963.00
+11.18%
8,961.00
Net PPE
4,679.00
+0.58%
4,652.00
+6.72%
4,359.00
+1.00%
4,316.00
Goodwill And Other Intangible Assets
39,544.00
-2.05%
40,371.00
+13.43%
35,590.00
+2.57%
34,698.00
Goodwill
28,344.00
+0.24%
28,277.00
+11.69%
25,317.00
+3.83%
24,383.00
Other Intangible Assets
11,200.00
-7.39%
12,094.00
+17.73%
10,273.00
-0.41%
10,315.00
Investments And Advances
27,745.00
+1.16%
27,428.00
-10.71%
30,719.00
+11.07%
27,657.00
Total Liabilities Net Minority Interest
77,468.00
+2.66%
75,463.00
+8.54%
69,523.00
+4.66%
66,425.00
Payables And Accrued Expenses
24,406.00
+7.64%
22,673.00
-1.51%
23,021.00
+8.57%
21,203.00
Payables
24,406.00
+7.64%
22,673.00
-1.51%
23,021.00
+8.57%
21,203.00
Accounts Payable
24,406.00
+7.64%
22,673.00
-1.51%
23,021.00
+8.57%
21,203.00
Current Debt And Capital Lease Obligation
1,249.00
-37.98%
2,014.00
+7.47%
1,874.00
+6.18%
1,765.00
Current Debt
1,249.00
-37.98%
2,014.00
+7.47%
1,874.00
+6.18%
1,765.00
Other Current Borrowings
1,249.00
-37.98%
2,014.00
+7.47%
1,874.00
+6.18%
1,765.00
Current Deferred Liabilities
1,493.00
-0.99%
1,508.00
+7.56%
1,402.00
+26.08%
1,112.00
Current Deferred Revenue
1,493.00
-0.99%
1,508.00
+7.56%
1,402.00
+26.08%
1,112.00
Long Term Debt And Capital Lease Obligation
30,797.00
+5.40%
29,218.00
+25.69%
23,246.00
+4.01%
22,349.00
Long Term Debt
30,797.00
+5.40%
29,218.00
+25.69%
23,246.00
+4.01%
22,349.00
Non Current Deferred Liabilities
2,110.00
-1.77%
2,148.00
+9.04%
1,970.00
-2.23%
2,015.00
Non Current Deferred Taxes Liabilities
2,110.00
-1.77%
2,148.00
+9.04%
1,970.00
-2.23%
2,015.00
Stockholders Equity
43,882.00
+6.21%
41,315.00
+5.11%
39,306.00
+8.45%
36,243.00
Common Stock Equity
43,882.00
+6.21%
41,315.00
+5.11%
39,306.00
+8.45%
36,243.00
Capital Stock
2.00
+0.00%
2.00
+0.00%
2.00
+0.00%
2.00
Common Stock
2.00
+0.00%
2.00
+0.00%
2.00
+0.00%
2.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
220.72
-2.97%
227.48
-2.40%
233.07
-2.05%
237.96
Ordinary Shares Number
220.72
-2.97%
227.48
-2.40%
233.07
-2.05%
237.96
Additional Paid In Capital
8,938.00
+0.30%
8,911.00
+0.48%
8,868.00
-2.38%
9,084.00
Retained Earnings
35,393.00
+5.50%
33,549.00
+5.67%
31,749.00
+7.09%
29,647.00
Gains Losses Not Affecting Retained Earnings
-451.00
+60.68%
-1,147.00
+12.64%
-1,313.00
+47.27%
-2,490.00
Minority Interest
144.00
+29.73%
111.00
+12.12%
99.00
+13.79%
87.00
Other Equity Adjustments
-451.00
+60.68%
-1,147.00
+12.64%
-1,313.00
+47.27%
-2,490.00
Total Equity Gross Minority Interest
44,026.00
+6.28%
41,426.00
+5.13%
39,405.00
+8.46%
36,330.00
Total Capitalization
74,679.00
+5.88%
70,533.00
+12.76%
62,552.00
+6.76%
58,592.00
Invested Capital
75,928.00
+4.66%
72,547.00
+12.61%
64,426.00
+6.74%
60,357.00
Total Debt
32,046.00
+2.61%
31,232.00
+24.33%
25,120.00
+4.17%
24,114.00
Net Debt
22,555.00
-1.70%
22,944.00
+23.39%
18,594.00
+11.16%
16,727.00
Net Tangible Assets
4,338.00
+359.53%
944.00
-74.60%
3,716.00
+140.52%
1,545.00
Tangible Book Value
4,338.00
+359.53%
944.00
-74.60%
3,716.00
+140.52%
1,545.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
4,290.00
-26.14%
5,808.00
-27.95%
8,061.00
-4.02%
8,399.00
Cash Flow From Continuing Operating Activities
4,290.00
-26.14%
5,808.00
-27.95%
8,061.00
-4.02%
8,399.00
Net Income From Continuing Operations
5,661.00
-5.19%
5,971.00
-0.33%
5,991.00
+1.75%
5,888.00
Depreciation And Amortization
1,546.00
+10.98%
1,393.00
-20.17%
1,745.00
+4.18%
1,675.00
Stock Based Compensation
276.00
+44.50%
191.00
-33.91%
289.00
+9.47%
264.00
Asset Impairment Charge
108.00
+4.85%
103.00
-76.91%
446.00
+6271.43%
7.00
Deferred Tax
-279.00
+25.40%
-374.00
+37.87%
-602.00
-423.48%
-115.00
Deferred Income Tax
-279.00
+25.40%
-374.00
+37.87%
-602.00
-423.48%
-115.00
Operating Gains Losses
255.00
+4.94%
243.00
-66.57%
727.00
+182.88%
257.00
Gain Loss On Investment Securities
653.00
+46.74%
445.00
-35.88%
694.00
+26.18%
550.00
Change In Working Capital
-3,277.00
-90.63%
-1,719.00
-221.31%
-535.00
-226.48%
423.00
Change In Receivables
-2,526.00
-269.84%
-683.00
+61.24%
-1,762.00
+29.80%
-2,510.00
Change In Payables And Accrued Expense
-720.00
-164.71%
-272.00
-116.59%
1,640.00
+99.03%
824.00
Change In Payable
-720.00
-164.71%
-272.00
-116.59%
1,640.00
+99.03%
824.00
Change In Account Payable
-720.00
-164.71%
-272.00
-116.59%
1,640.00
+99.03%
824.00
Change In Other Working Capital
-316.00
-195.76%
330.00
+70.10%
194.00
+143.50%
-446.00
Change In Other Current Assets
57.00
-92.36%
746.00
+198.94%
-754.00
-623.61%
144.00
Investing Cash Flow
-1,344.00
+73.99%
-5,167.00
+7.27%
-5,572.00
-22.19%
-4,560.00
Cash Flow From Continuing Investing Activities
-1,344.00
+73.99%
-5,167.00
+7.27%
-5,572.00
-22.19%
-4,560.00
Net PPE Purchase And Sale
-1,116.00
+11.15%
-1,256.00
+3.09%
-1,296.00
-12.50%
-1,152.00
Purchase Of PPE
-1,116.00
+11.15%
-1,256.00
+3.09%
-1,296.00
-12.50%
-1,152.00
Capital Expenditure
-1,116.00
+11.15%
-1,256.00
+3.09%
-1,296.00
-12.50%
-1,152.00
Net Investment Purchase And Sale
69.00
-88.23%
586.00
+121.70%
-2,700.00
-15.48%
-2,338.00
Purchase Of Investment
-15,026.00
+16.46%
-17,986.00
-10.78%
-16,236.00
+34.92%
-24,946.00
Sale Of Investment
15,095.00
-18.72%
18,572.00
+37.20%
13,536.00
-40.13%
22,608.00
Net Business Purchase And Sale
88.00
+101.98%
-4,446.00
-186.47%
-1,552.00
-139.14%
-649.00
Purchase Of Business
—
-4,809.00
-209.86%
-1,552.00
-139.14%
-649.00
Gain Loss On Sale Of Business
0.00
+100.00%
-201.00
0.00
0.00
Net Other Investing Changes
-385.00
-654.90%
-51.00
-112.50%
-24.00
+94.30%
-421.00
Financing Cash Flow
-1,738.00
-245.68%
1,193.00
+135.62%
-3,349.00
-154.10%
-1,318.00
Cash Flow From Continuing Financing Activities
-1,738.00
-245.68%
1,193.00
+135.62%
-3,349.00
-154.10%
-1,318.00
Net Issuance Payments Of Debt
2,327.00
-57.59%
5,487.00
+728.85%
662.00
-63.12%
1,795.00
Issuance Of Debt
6,194.00
-22.43%
7,985.00
+174.12%
2,913.00
-45.74%
5,369.00
Repayment Of Debt
-3,867.00
-54.80%
-2,498.00
-10.97%
-2,251.00
+37.02%
-3,574.00
Long Term Debt Issuance
2,991.00
-61.21%
7,710.00
+199.53%
2,574.00
-16.18%
3,071.00
Long Term Debt Payments
-2,147.00
-30.12%
-1,650.00
+13.57%
-1,909.00
-0.53%
-1,899.00
Net Long Term Debt Issuance
844.00
-86.07%
6,060.00
+811.28%
665.00
-43.26%
1,172.00
Short Term Debt Issuance
3,203.00
+1064.73%
275.00
-18.88%
339.00
-85.25%
2,298.00
Short Term Debt Payments
-1,720.00
-102.83%
-848.00
-147.95%
-342.00
+79.58%
-1,675.00
Net Short Term Debt Issuance
1,483.00
+358.81%
-573.00
-19000.00%
-3.00
-100.48%
623.00
Net Common Stock Issuance
-2,605.00
+10.17%
-2,900.00
-8.37%
-2,676.00
-15.54%
-2,316.00
Common Stock Payments
-2,605.00
+10.17%
-2,900.00
-8.37%
-2,676.00
-15.54%
-2,316.00
Common Stock Dividend Paid
-1,529.00
-1.39%
-1,508.00
-8.10%
-1,395.00
-13.51%
-1,229.00
Cash Dividends Paid
-1,529.00
-1.39%
-1,508.00
-8.10%
-1,395.00
-13.51%
-1,229.00
Repurchase Of Capital Stock
-2,605.00
+10.17%
-2,900.00
-8.37%
-2,676.00
-15.54%
-2,316.00
Proceeds From Stock Option Exercised
79.00
-64.25%
221.00
+45.39%
152.00
-16.48%
182.00
Net Other Financing Charges
-10.00
+90.65%
-107.00
-16.30%
-92.00
-76.92%
-52.00
Changes In Cash
1,208.00
-34.13%
1,834.00
+313.26%
-860.00
-134.11%
2,521.00
Effect Of Exchange Rate Changes
-5.00
+16.67%
-6.00
-500.00%
-1.00
+92.86%
-14.00
Beginning Cash Position
8,288.00
+27.00%
6,526.00
-11.66%
7,387.00
+51.37%
4,880.00
End Cash Position
9,491.00
+14.51%
8,288.00
+27.00%
6,526.00
-11.66%
7,387.00
Free Cash Flow
3,174.00
-30.27%
4,552.00
-32.71%
6,765.00
-6.65%
7,247.00
Earnings Losses From Equity Investments
-398.00
-39700.00%
-1.00
-103.03%
33.00
+111.26%
-293.00
Other Cash Adjustment Outside Changein Cash
0.00
+100.00%
-66.00
0.00
0.00
Sale Of Business
88.00
-75.76%
363.00
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category